UCLE · US Nuclear Corp.
Substantial doubt about the company's ability to continue as a going concern.
“The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company recorded a net loss of $187,086 for the three months ended March 31, 2026, and had an accumulated deficit of $21,424,243 as of March 31, 2026, which raises substantial doubt about its ability to continue as a going concern.”View the 10-Q filed Oct 13, 2026
Price & Indicators
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
Versus peers
Scientific & Technical Instruments — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
UCLE
this stock
US Nuclear Corp.
|
$1.44M | -27.4% | -1.0% | — | 0.0% |
|
KEYS
Keysight Technologies, Inc.
|
$57.18B | +65.3% | +8.0% | 46.0 | 1.4% |
|
GRMN
Garmin Ltd
|
$55.19B | +41.1% | +15.1% | 29.5 | 1.7% |
|
COHR
Coherent Corp.
|
$45.44B | +25.7% | +19.2% | 56.3 | 5.6% |
|
TDY
Teledyne Technologies Inc
|
$28.73B | +21.3% | -4.6% | 30.0 | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| UCLE | +87.5% | +0.0% | -68.8% | +50.0% | -27.4% |
| SPY | -2.0% | +0.2% | +6.7% | +0.1% | +11.9% |
| vs SPY | +89.5% | -0.2% | -75.5% | +49.9% | -39.4% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.